The vaccine will also come in Bangladesh, the dose is only 254

Bangladesh will get a ticker dose if one of the two Oxford-Astrazenaca or United States of Novavax in the United Kingdom. Global Alliance for Vaccines and Immunization (Gavy) gave good news for 92 countries including Bangladesh, provided by the world's low and low middle-income countries. On Friday night Gavy said in a statement that in 2021, the possible safe and effective ticker for low and middle-income countries, the Seram Institute of India (SII), Gavy and Bill and Melinda Gatez to accelerate production and distribution of 10 million doses. Under the agreement, Oxford-Astrazeneca and Novavax will not be provided by 9 million doses after getting the vaccine approval. And this supply will be in charge of India's Siram Institute. Bill and Melinda Gates Foundation will provide 15 million dollars to the company. This initiative has been taken under the 'CovaX Advanced Market Commitment (AMC) structure. According to the agreement, every dosage vaccine will cost the maximum three dollars (about 254 taka). Gavi's chief executive officer said. Seth Berkel said, "We have seen many times, risky countries are behind the new medical, disease testing and new vaccine. We do not want this to do this in the tax of taxoner. 'It is noted that the United States and the United Kingdom are trying to ensure possible vaccinations by making the purchase agreement with the purchase agreement with those organizations who are ahead in the invention of taxation. If you prove the functionality of the ticker, the vaccine is almost sure at the beginning of the two countries. Especially in the United Kingdom vaccine, there is a contract with at least four organizations. On the other hand, when the World Health Organization, he had to be fairly vaccinated for everyone, but it was not a visible activity in the work so much. On Friday, due to the initiative of International Alliance Gav and Melinda Gates and Seram Institute of India, the initiative of the Seram Institute of India, there was an opportunity to reach vaccinations to the poor people of the world.